{
  "documentMetadata": {
    "title": "Toxoplasmosis, HIV/AIDS",
    "lastUpdated": "2022-07-24",
    "sourceFile": "Toxoplasmosis, HIV_AIDS.pdf"
  },
  "content": [
    {
      "type": "header",
      "level": 1,
      "text": "Clinical Setting"
    },
    {
      "type": "list",
      "items": [
        "Cerebral toxoplasmosis in HIV-positive or AIDS patients, usually seen as ring-enhancing lesions on CT or MRI",
        "Toxoplasmosis can also present as disseminated infection, though much less common.",
        "Most individuals (>95%) will have IgG evidence of preexisting latent infection, but acute new infection also reported.",
        "Antibody titers often very low, borderline positive.",
        "Regimens for:",
        "Treatment",
        "Primary prophylaxis in AIDS patients who are IgG toxoplasma antibody positive and who have CD4 count <100/mL",
        "Chronic suppression after treatment",
        "See guidelines: clinicalinfo.HIV.gov"
      ]
    },
    {
      "type": "header",
      "level": 1,
      "text": "Etiologies"
    },
    {
      "type": "list",
      "items": [
        "Toxoplasma gondii"
      ]
    },
    {
      "type": "header",
      "level": 1,
      "text": "Primary Regimens"
    },
    {
      "type": "nestedContent",
      "content": [
        {
          "type": "paragraph",
          "text": "Treatment:"
        },
        {
          "type": "list",
          "items": [
            "Treat for minimum of 6 weeks after resolution of signs/symptoms, followed by suppressive therapy (see below)"
          ]
        },
        {
          "type": "regimen",
          "regimenData": {
            "intent": "treatment",
            "components": [
              {
                "drug": "Pyrimethamine",
                "dose": "200 mg x 1 po, then (75 mg po daily for those weighing \u226560 kg) or (50 mg po daily for those weighing <60 kg)"
              },
              {
                "drug": "Sulfadiazine",
                "dose": "(1.5 gm if \u226560 kg or 1 gm if <60 kg)",
                "route": "po",
                "frequency": "q6h",
                "connector": "+"
              },
              {
                "drug": "Folinic acid",
                "dose": "10-25 mg",
                "route": "po",
                "frequency": "daily",
                "connector": "+"
              }
            ]
          }
        }
      ]
    },
    {
      "type": "nestedContent",
      "content": [
        {
          "type": "paragraph",
          "text": "Primary Prophylaxis:"
        },
        {
          "type": "list",
          "items": [
            "Can discontinue if CD4 count >200 for 3 months"
          ]
        },
        {
          "type": "regimen",
          "regimenData": {
            "intent": "prophylaxis",
            "components": [
              {
                "drug": "TMP-SMX-DS",
                "dose": "1 tab",
                "route": "po",
                "frequency": "q24h"
              }
            ]
          }
        }
      ]
    },
    {
      "type": "nestedContent",
      "content": [
        {
          "type": "paragraph",
          "text": "Chronic Suppression (secondary prophylaxis):"
        },
        {
          "type": "regimen",
          "regimenData": {
            "intent": "suppression",
            "components": [
              {
                "drug": "Sulfadiazine",
                "dose": "2-4 gm",
                "route": "po",
                "frequency": "divided in 2-4 doses/day"
              },
              {
                "drug": "Pyrimethamine",
                "dose": "25-50 mg",
                "route": "po",
                "frequency": "q24h",
                "connector": "+"
              },
              {
                "drug": "Folinic acid",
                "dose": "10-25 mg",
                "route": "po",
                "frequency": "q24h",
                "connector": "+"
              }
            ]
          }
        },
        {
          "type": "regimen",
          "regimenData": {
            "intent": "suppression",
            "components": [
              {
                "drug": "TMP-SMX-DS",
                "dose": "1 tab",
                "route": "po",
                "frequency": "BID (preferred) or q24h"
              }
            ],
            "notes": "--less clinical experience but may be used to reduce pills or if pyrimethamine not available."
          }
        },
        {
          "type": "list",
          "items": [
            "Can discontinue suppression if CD4 count >200 for 6 months"
          ]
        }
      ]
    },
    {
      "type": "header",
      "level": 1,
      "text": "Alternative Regimens"
    },
    {
      "type": "nestedContent",
      "content": [
        {
          "type": "paragraph",
          "text": "Treatment:"
        },
        {
          "type": "list",
          "items": [
            "Treat 4-6 weeks after resolution of signs/symptoms, then suppression."
          ]
        },
        {
          "type": "regimen",
          "regimenData": {
            "intent": "treatment",
            "components": [
              {
                "drug": "Pyrimethamine",
                "dose": "75 mg po daily (Wt \u226560 kg) or 50 mg po daily (Wt <60 kg)"
              },
              {
                "drug": "Folinic acid",
                "dose": "10-25 mg/day po",
                "connector": "+"
              },
              {
                "drug": "Clindamycin",
                "dose": "600 mg",
                "route": "po or IV",
                "frequency": "q6h",
                "connector": "+"
              }
            ]
          }
        },
        {
          "type": "regimen",
          "regimenData": {
            "intent": "treatment",
            "components": [
              {
                "drug": "TMP-SMX",
                "dose": "5/25 mg/kg",
                "frequency": "q12h",
                "route": "po or IV"
              }
            ]
          }
        },
        {
          "type": "regimen",
          "regimenData": {
            "intent": "treatment",
            "components": [
              {
                "drug": "Pyrimethamine",
                "dose": "75 mg po daily (Wt \u226560 kg) or 50 mg po daily (Wt <60 kg)"
              },
              {
                "drug": "Folinic acid",
                "dose": "10-25 mg/day po",
                "connector": "+"
              },
              {
                "drug": "Atovaquone",
                "dose": "1,500 mg",
                "route": "po",
                "frequency": "bid with food",
                "connector": "+"
              }
            ]
          }
        },
        {
          "type": "regimen",
          "regimenData": {
            "intent": "treatment",
            "components": [
              {
                "drug": "Atovaquone",
                "dose": "1,500 mg",
                "route": "po",
                "frequency": "bid with food"
              },
              {
                "drug": "Sulfadiazine",
                "dose": "1.5 gm (Wt \u226560 kg) or 1 gm (Wt <60 kg",
                "frequency": "q6h",
                "connector": "+"
              }
            ]
          }
        },
        {
          "type": "regimen",
          "regimenData": {
            "intent": "treatment",
            "components": [
              {
                "drug": "Atovaquone",
                "dose": "1,500 mg",
                "route": "po",
                "frequency": "bid with food"
              }
            ]
          }
        },
        {
          "type": "regimen",
          "regimenData": {
            "intent": "treatment",
            "components": [
              {
                "drug": "Pyrimethamine",
                "dose": "75 mg po daily (Wt \u226560 kg) or 50 mg po daily (Wt <60 kg)"
              },
              {
                "drug": "Folinic acid",
                "dose": "10-25 mg/day po",
                "connector": "+"
              },
              {
                "drug": "Azithromycin",
                "dose": "900-1,200 mg",
                "route": "po",
                "frequency": "once daily",
                "connector": "+"
              }
            ]
          }
        }
      ]
    },
    {
      "type": "nestedContent",
      "content": [
        {
          "type": "paragraph",
          "text": "Primary Prophylaxis:"
        },
        {
          "type": "regimen",
          "regimenData": {
            "intent": "prophylaxis",
            "components": [
              {
                "drug": "TMP-SMX-DS",
                "dose": "1 tab",
                "route": "po",
                "frequency": "3x/week"
              }
            ]
          }
        },
        {
          "type": "regimen",
          "regimenData": {
            "intent": "prophylaxis",
            "components": [
              {
                "drug": "TMP-SMX-SS",
                "dose": "1 tab",
                "route": "po",
                "frequency": "daily"
              }
            ]
          }
        },
        {
          "type": "regimen",
          "regimenData": {
            "intent": "prophylaxis",
            "components": [
              {
                "drug": "Dapsone",
                "dose": "50 mg",
                "route": "po",
                "frequency": "q24h"
              },
              {
                "drug": "Pyrimethamine",
                "dose": "50 mg",
                "route": "po",
                "frequency": "once weekly",
                "connector": "+"
              },
              {
                "drug": "Folinic acid",
                "dose": "25 mg",
                "route": "po",
                "frequency": "once weekly",
                "connector": "+"
              }
            ]
          }
        },
        {
          "type": "regimen",
          "regimenData": {
            "intent": "prophylaxis",
            "components": [
              {
                "drug": "Atovaquone",
                "dose": "1500 mg",
                "route": "po",
                "frequency": "q24h"
              },
              {
                "drug": "Pyrimethamine",
                "dose": "25 mg",
                "route": "po",
                "frequency": "q24h",
                "connector": "+"
              },
              {
                "drug": "folinic acid",
                "dose": "10 mg",
                "route": "po",
                "frequency": "q24h",
                "connector": "+"
              }
            ]
          }
        },
        {
          "type": "regimen",
          "regimenData": {
            "intent": "prophylaxis",
            "components": [
              {
                "drug": "Dapsone",
                "dose": "200 mg"
              },
              {
                "drug": "Pyrimethamine",
                "dose": "75 mg",
                "connector": "+"
              },
              {
                "drug": "Folinic acid",
                "dose": "25 mg",
                "route": "po",
                "frequency": "once weekly",
                "connector": "+"
              }
            ]
          }
        }
      ]
    },
    {
      "type": "nestedContent",
      "content": [
        {
          "type": "paragraph",
          "text": "Chronic Suppression:"
        },
        {
          "type": "regimen",
          "regimenData": {
            "intent": "suppression",
            "components": [
              {
                "drug": "Clindamycin",
                "dose": "600 mg",
                "route": "po",
                "frequency": "q8h"
              },
              {
                "drug": "Pyrimethamine",
                "dose": "25-50 mg",
                "route": "po",
                "frequency": "q24h",
                "connector": "+"
              },
              {
                "drug": "Folinic acid",
                "dose": "10-25 mg",
                "route": "po",
                "frequency": "q24h",
                "connector": "+"
              }
            ]
          }
        },
        {
          "type": "regimen",
          "regimenData": {
            "intent": "suppression",
            "components": [
              {
                "drug": "Atovaquone",
                "dose": "750 mg",
                "route": "po",
                "frequency": "q6-12h"
              },
              {
                "drug": "Pyrimethamine",
                "dose": "25 mg",
                "route": "po",
                "frequency": "q24h",
                "connector": "+"
              },
              {
                "drug": "Folinic acid",
                "dose": "10 mg",
                "route": "po",
                "frequency": "q24h",
                "connector": "+"
              },
              {
                "drug": "Sulfadiazine",
                "dose": "2 to 4 gm",
                "route": "po",
                "frequency": "daily",
                "connector": "or"
              }
            ]
          }
        }
      ]
    },
    {
      "type": "header",
      "level": 1,
      "text": "Comments"
    },
    {
      "type": "nestedContent",
      "content": [
        {
          "type": "paragraph",
          "text": "Treatment:"
        },
        {
          "type": "list",
          "items": [
            "Use alternative (non-sulfa) regimen for patients with severe sulfa allergy.",
            "If multiple ring-enhancing brain lesions (CT or MRI), >85% of patients respond to 7-10 days of empiric therapy; if no response in 14 days or clinical worsening in first week, suggest brain biopsy.",
            "Pyrimethamine penetrates brain even if no inflammation",
            "Folinic acid prevents pyrimethamine hematologic toxicity",
            "Most experts prefer and guidelines recommend pyrimethamine regimens, but now VERY expensive in the US. Meta analysis suggests TMP-SMX is a reasonable alternative HIV Med 2016"
          ]
        }
      ]
    },
    {
      "type": "nestedContent",
      "content": [
        {
          "type": "paragraph",
          "text": "Primary Prophylaxis:"
        },
        {
          "type": "list",
          "items": [
            "Prophylaxis for pneumocystis pneumonia (PJP) (Pneumocystis jiroveci) also effective against toxoplasmosis. See guidelines: clinicalinfo.HIV.gov."
          ]
        }
      ]
    },
    {
      "type": "nestedContent",
      "content": [
        {
          "type": "paragraph",
          "text": "Chronic Suppression:"
        },
        {
          "type": "list",
          "items": [
            "(Pyrimethamine + sulfadiazine) prevents PCP and toxoplasmosis.",
            "(Clindamycin + Pyrimethamine) prevents toxoplasmosis only.",
            "If PJP is present or a concern, drugs must cover both organisms"
          ]
        }
      ]
    }
  ]
}
